Astria Therapeutics is a clinical-stage biopharmaceutical company focused on developing treatments for rare diseases and lipid disorders.

Astria Therapeutics, Inc. is a clinical-stage biopharmaceutical company making significant strides in treating rare diseases and serious lipid disorders, offering hope for patients and a promising future in the biotechnology sector.

Astria Therapeutics Inc. continues to navigate market volatility while maintaining its strategic focus on developing innovative treatments for rare diseases and lipid disorders.

Astria Therapeutics, a clinical-stage biopharmaceutical company, is a beacon of hope for those affected by rare diseases and serious lipid disorders, with a commitment to innovation and patient care that is shaping the future of healthcare.